Patents Assigned to Shanghai Haikang Pharmaceutical Tech. & Deve. Co., LTD
  • Antibody against carcinoembryonic antigen and uses thereof
    Patent number: 9056911
    Abstract: The invention discloses a humanized chimeric monoclonal antibody against carcinoembryonic antigen (CEA), polynucleotides encoding the antibody, expression vectors comprising the polynucleotides, and host cells containing the expression vectors. The invention also discloses uses of the antibody, polynucleotides, vectors and host cells for manufacturing medicaments for diagnosis and/or treatment of tumors.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: June 16, 2015
    Assignee: Shanghai Haikang Pharmaceutical Tech. & Deve. Co., Ltd.
    Inventors: Zhihua Yang, Yuliang Ran
  • Antibody Against Carcinoembryonic Antigen and Uses Thereof
    Publication number: 20130123471
    Abstract: The invention discloses a humanized chimeric monoclonal antibody against carcinoembryonic antigen (CEA), polynucleotides encoding the antibody, expression vectors comprising the polynucleotides, and host cells containing the expression vectors. The invention also discloses uses of the antibody, polynucleotides, vectors and host cells for manufacturing medicaments for diagnosis and/or treatment of tumors.
    Type: Application
    Filed: March 16, 2011
    Publication date: May 16, 2013
    Applicant: Shanghai Haikang Pharmaceutical Tech. & Deve. Co., LTD
    Inventors: Zhihua Yang, Yuliang Ran